Evergy Inc. Common Stock vs Heron Therapeutics Inc — how do they compare? Evergy Inc. Common Stock trades at $80.8 (market cap $18.57B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: Evergy Inc. Common Stock is far larger — about 273× Heron Therapeutics Inc's market cap, and Evergy Inc. Common Stock pays a 3.45% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Evergy Inc. Common Stock for 0 Days and Heron Therapeutics Inc for 35 Days on average.
| EVRG | HRTX | |
|---|---|---|
Market Cap | $18.57B | $68.01M |
Volume | 1,988,675 | 1,891,941 |
Sector | Utilities | Health |
52-Week High | $88.13 | $1.49 |
52-Week Low | $72.31 | $0.27 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $35.04B | $174.75M |
Dividend Yield | 3.45% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Evergy is a regulated electric utility serving customers in Kansas and Missouri. Its operations include electricity generation, transmission, and distribution through its integrated utility subsidiaries.
Read more on EVRG →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →